Cat #:
3025

ELISpot Human IFN-γ Kit + SARS-CoV-2 Peptide Pool

£ 280.00

Shipped within 2-3 days
Product Details
Application: ELISpot
Analyte: IFN-γ
Reactivity: Human
Storage: Store plates and reagents between 2 and 8°C. Peptide pool vial must be stored at -20 °C or below.
Shelf Life: 12 months
Peptide Pools​: ImmuneSelect SARS-CoV-2 (100 peptides covering the immunodominant epitopes)
Plates​: ELISpot plate precoated with IFN-γ capture antibody
Detection mAb​​: Biotinylated recombinant IFN-γ antibody
Enzyme conjugate​: Streptavidin-ALP (Alkaline Phosphatase)
Substrate: BCIP/NBT Ready-to-use solution
Blocking agent: Bovine Serum Albumin (BSA)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, a global pandemic that has resulted in millions of deaths and and significant social and economic disruption. The virus primarily affects the respiratory system but can also cause a range of severe complications to multiple organ systems,  from mild respiratory illness to severe pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. Sometimes it can lead to chronic effects after acute infection (Long COVID). Early detection, via antigen or PCR tests, had been critical during the emergency phase of the pandemic, allowing for isolation of infected individuals, contact tracing, and treatment interventions. As the virus turns endemic, accurate diagnosis is now essential for better for researchers to understand the epidemiology of the virus, identifying new variants, and guiding vaccine development and deployment strategies

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Enzyme-Linked ImmunoSpot (ELISpot) Human Kit is a highly sensitive method used to detect and quantify individual cells that secrete IFN-γ after stimulation with the ImmuneSelect SARS-CoV-2 Peptide Pool. This assay is utilized in immunology to monitor cellular immune responses at the single-cell level and reliably detects and measures IL-2 secretion by stimulated effector cells.

 

Description

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, a global pandemic that has resulted in millions of deaths and and significant social and economic disruption. The virus primarily affects the respiratory system but can also cause a range of severe complications to multiple organ systems,  from mild respiratory illness to severe pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. Sometimes it can lead to chronic effects after acute infection (Long COVID). Early detection, via antigen or PCR tests, had been critical during the emergency phase of the pandemic, allowing for isolation of infected individuals, contact tracing, and treatment interventions. As the virus turns endemic, accurate diagnosis is now essential for better for researchers to understand the epidemiology of the virus, identifying new variants, and guiding vaccine development and deployment strategies

Application

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Enzyme-Linked ImmunoSpot (ELISpot) Human Kit is a highly sensitive method used to detect and quantify individual cells that secrete IFN-γ after stimulation with the ImmuneSelect SARS-CoV-2 Peptide Pool. This assay is utilized in immunology to monitor cellular immune responses at the single-cell level and reliably detects and measures IL-2 secretion by stimulated effector cells.

 

You may also like

Frequently Asked Questions

Virax Biolabs develops and provides immunology-profiling solutions, with a focus on T cell diagnostics and immune monitoring. Their offerings include research-use products (e.g., peptide pools, ELISpot/FluoroSpot kits, high-affinity antibodies) as well as custom immunology services (such as recombinant antibody engineering, peptide synthesis and protein sequencing).

Virax Biolabs offers a comprehensive range of products to support immunology research and diagnostic development. Their primary product categories include pathogen-specific peptide pools that enable T cell stimulation and immune-response analysis, ELISpot and FluoroSpot kits designed for measuring cytokine secretion and other immune markers, and high-affinity antibodies suitable for use in assays such as ELISA, flow cytometry, and ELISpot. Together, these products provide researchers with precise tools for profiling immune responses in various disease and vaccine studies.

Virax Biolabs provides a range of custom immunology services to meet the diverse needs of academic and industry clients. These services include recombinant antibody engineering, which involves antigen discovery, sequencing, formatting, and bio-conjugation. They also offer custom peptide synthesis and protein sequencing using advanced mass spectrometry, as well as laboratory services that support ELISA, ELISpot, FluoroSpot, and flow cytometry assays. These custom services are designed to help researchers accelerate discovery and optimize immune-response studies.

Virax Biolabs primarily serves researchers and organizations engaged in immunology, infectious disease, and vaccine development. Their customer base includes academic laboratories, biotechnology companies, and pharmaceutical firms that require high-quality immune-profiling tools and diagnostic support. By providing both off-the-shelf research products and tailored immunology services, Virax Biolabs enables scientists to investigate T cell activity, evaluate vaccine efficacy, and develop new diagnostic platforms.

Virax Biolabs’ headquarters is located at BioCity Glasgow, Bo’Ness Road, Newhouse, Lanarkshire, ML1 5UH, United Kingdom. Inquiries can be made through the “Contact” section of their website at viraxbiolabs.com.

Many of Virax Biolabs’ products, including peptide pools and ELISpot kits, are intended for research use in immune-profiling and in-vitro studies. However, the company is also developing in-vitro diagnostic (IVD) platforms and T cell diagnostics for applications such as chronic inflammation and immune exhaustion. The intended use and regulatory status vary by product, so customers should refer to the specific product details or contact the company directly for clarification.

Join the Virax Research Network